News

Deal Announcements

Amyris Bio Nets $48 Million Venture Capital Funding

Tuesday, April 6, 2010 5:33:00 AM PDT | VentureDeal Staff
Emeryville, California  --  Biotechnology company Amyris Biotechnologies has raised $47.8 million in a new round of institutional venture capital investment.

Amyris says that it is developing cost-effective and high-value natural compounds by leveraging breakthroughs in synthetic biology.

Temasek Holdings made the investment.  The company did not say how the funding proceeds would be used.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1